Concert Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Concert Wealth Management's BMY Position: Q3 2017 in Review
Concert Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2017, closing a stake of 9,818 shares — an estimated $548K sold.
Concert Wealth Management first reported a position in BMY in Q2 2013 and held it in 17 quarters. The position peaked at $5.24M in Q2 2015. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.
- Concert Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2017 after selling out during the quarter.
- Concert Wealth Management sold 9,818 Bristol-Myers Squibb shares in Q3 2017, an estimated $548K.
- Concert Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 17 quarters.
- Concert Wealth Management's Bristol-Myers Squibb position peaked at $5.24M in Q2 2015.
- 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.
Based on Concert Wealth Management's 13F filing for Q3 2017, filed 14 Nov 2017.